Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

CTMX

CytomX Therapeutics (CTMX)

CytomX Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CTMX
FechaHoraFuenteTítuloSímboloCompañía
27/03/202315:13Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CTMXCytomX Therapeutics Inc
27/03/202315:09Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:CTMXCytomX Therapeutics Inc
22/03/202318:23GlobeNewswire Inc.CytomX Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 27, 2023NASDAQ:CTMXCytomX Therapeutics Inc
20/03/202317:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
10/03/202314:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTMXCytomX Therapeutics Inc
28/02/202315:05GlobeNewswire Inc.CytomX Therapeutics to Present at Upcoming March Investor ConferencesNASDAQ:CTMXCytomX Therapeutics Inc
14/02/202315:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CTMXCytomX Therapeutics Inc
26/01/202306:00GlobeNewswire Inc.CytomX Therapeutics Announces Milestone Achievement in Probody® T-Cell Engaging Bispecific (TCB) Collaboration with AstellasNASDAQ:CTMXCytomX Therapeutics Inc
17/01/202315:05GlobeNewswire Inc.CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Investor ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
05/01/202316:16Dow Jones NewsCytomX Shares Climb 58% on Research Collaboration With ModernaNASDAQ:CTMXCytomX Therapeutics Inc
05/01/202315:05GlobeNewswire Inc.CytomX Therapeutics Provides Business Update and Outlines 2023 Company PrioritiesNASDAQ:CTMXCytomX Therapeutics Inc
05/01/202315:05GlobeNewswire Inc.CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated TherapeuticsNASDAQ:CTMXCytomX Therapeutics Inc
22/12/202216:00GlobeNewswire Inc.CytomX Therapeutics to Outline 2023 Company Priorities and Provide Pipeline Update on January 5, 2023NASDAQ:CTMXCytomX Therapeutics Inc
20/12/202216:00GlobeNewswire Inc.CytomX Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
07/12/202215:30GlobeNewswire Inc.CytomX Therapeutics to Present Phase 2 Data for Praluzatamab Ravtansine (CX-2009) in Patients with Advanced Breast Cancer at the San Antonio Breast Cancer SymposiumNASDAQ:CTMXCytomX Therapeutics Inc
18/11/202205:25TipRanksCytomX Therapeutics (CTMX) Receives a Hold from H.C. WainwrightNASDAQ:CTMXCytomX Therapeutics Inc
17/11/202210:17Dow Jones NewsCytomX Therapeutics Shares Rally on Regeneron PactNASDAQ:CTMXCytomX Therapeutics Inc
17/11/202208:25TipRanksMizuho Securities Remains a Hold on CytomX Therapeutics (CTMX)NASDAQ:CTMXCytomX Therapeutics Inc
17/11/202206:57Dow Jones NewsRegeneron, CytomX Set Cancer-Therapy CollaborationNASDAQ:CTMXCytomX Therapeutics Inc
17/11/202206:00PR Newswire (US)Regeneron and CytomX Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of CancerNASDAQ:CTMXCytomX Therapeutics Inc
17/11/202206:00GlobeNewswire Inc.CytomX and Regeneron Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of CancerNASDAQ:CTMXCytomX Therapeutics Inc
14/11/202206:06TipRanksJ.P. Morgan downgrades CytomX Therapeutics (CTMX) to a SellNASDAQ:CTMXCytomX Therapeutics Inc
09/11/202209:16TipRanksCytomX Therapeutics (CTMX) Receives a Buy from BMO CapitalNASDAQ:CTMXCytomX Therapeutics Inc
09/11/202205:35TipRanksCytomX Therapeutics (CTMX) Gets a Hold from H.C. WainwrightNASDAQ:CTMXCytomX Therapeutics Inc
09/11/202202:35TipRanksMizuho Securities Sticks to Their Hold Rating for CytomX Therapeutics (CTMX)NASDAQ:CTMXCytomX Therapeutics Inc
08/11/202215:10GlobeNewswire Inc.CytomX Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:CTMXCytomX Therapeutics Inc
08/11/202215:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CTMXCytomX Therapeutics Inc
07/11/202215:15GlobeNewswire Inc.CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Interferon Alpha-2b (CX-801) at the SITC 2022 Annual MeetingNASDAQ:CTMXCytomX Therapeutics Inc
02/11/202215:15GlobeNewswire Inc.CytomX Therapeutics to Present at Upcoming November Investor ConferencesNASDAQ:CTMXCytomX Therapeutics Inc
01/11/202207:00GlobeNewswire Inc.CytomX Therapeutics to Report Third Quarter 2022 Financial Results on November 8, 2022NASDAQ:CTMXCytomX Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CTMX

Su Consulta Reciente